Zhang M, Kim S, Yang H
Nat Commun. 2023; 14(1):7847.
PMID: 38030655
PMC: 10687137.
DOI: 10.1038/s41467-023-43716-y.
Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S
J Transl Med. 2023; 21(1):132.
PMID: 36803784
PMC: 9940387.
DOI: 10.1186/s12967-023-03985-z.
Mo H, Liu X, Xue Y, Chen H, Guo S, Li Z
Mol Cancer. 2022; 21(1):171.
PMID: 36042494
PMC: 9426012.
DOI: 10.1186/s12943-022-01642-5.
Nussinov R, Tsai C, Jang H
Biophys Chem. 2022; 283:106766.
PMID: 35121384
PMC: 8898294.
DOI: 10.1016/j.bpc.2022.106766.
Malengier-Devlies B, Metzemaekers M, Wouters C, Proost P, Matthys P
Front Immunol. 2021; 12:766620.
PMID: 34966386
PMC: 8710701.
DOI: 10.3389/fimmu.2021.766620.
Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells.
La T, Chen S, Guo T, Zhao X, Teng L, Li D
Theranostics. 2021; 11(19):9605-9622.
PMID: 34646389
PMC: 8490506.
DOI: 10.7150/thno.63763.
Alterations in TGFβ signaling during prostate cancer progression.
Thompson-Elliott B, Johnson R, Khan S
Am J Clin Exp Urol. 2021; 9(4):318-328.
PMID: 34541030
PMC: 8446771.
Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways.
Bahrami F, Mekkawy A, Badar S, Morris D, Pourgholami M
Am J Cancer Res. 2021; 11(6):3098-3110.
PMID: 34249447
PMC: 8263694.
Paeonol exerts anti‑tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β‑catenin signaling pathway.
Liu L, Shi R, Chen Z
Int J Mol Med. 2020; 46(2):675-684.
PMID: 32626954
PMC: 7307818.
DOI: 10.3892/ijmm.2020.4629.
Increased O-GlcNAcylation of c-Myc Promotes Pre-B Cell Proliferation.
Lee D, Kwon N, Lee W, Lee M, Kim D, Kim J
Cells. 2020; 9(1).
PMID: 31936366
PMC: 7016991.
DOI: 10.3390/cells9010158.
High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer.
Katsuta E, Yan L, Takeshita T, McDonald K, Dasgupta S, Opyrchal M
Int J Mol Sci. 2020; 21(1).
PMID: 31905596
PMC: 6981812.
DOI: 10.3390/ijms21010217.
Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.
Abdel-Azim H, Sun W, Wu L
Pharmacol Ther. 2019; 204:107403.
PMID: 31470030
PMC: 6881549.
DOI: 10.1016/j.pharmthera.2019.107403.
Essential role of JunD in cell proliferation is mediated via MYC signaling in prostate cancer cells.
Elliott B, Millena A, Matyunina L, Zhang M, Zou J, Wang G
Cancer Lett. 2019; 448:155-167.
PMID: 30763715
PMC: 6414252.
DOI: 10.1016/j.canlet.2019.02.005.
Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer.
Zakiryanova G, Kustova E, Urazalieva N, Baimuchametov E, Nakisbekov N, Shurin M
Int J Mol Sci. 2019; 20(3).
PMID: 30754645
PMC: 6387292.
DOI: 10.3390/ijms20030756.
The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues.
Goetzman E, Prochownik E
Front Endocrinol (Lausanne). 2018; 9:129.
PMID: 29706933
PMC: 5907532.
DOI: 10.3389/fendo.2018.00129.
SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.
Hermosilla V, Salgado G, Riffo E, Escobar D, Hepp M, Farkas C
Mol Oncol. 2018; 12(7):1026-1046.
PMID: 29689621
PMC: 6026872.
DOI: 10.1002/1878-0261.12308.
The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.
Lawrence S, Corriden R, Nizet V
Microbiol Mol Biol Rev. 2018; 82(1).
PMID: 29436479
PMC: 5813886.
DOI: 10.1128/MMBR.00057-17.
Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase.
Ersching J, Efeyan A, Mesin L, Jacobsen J, Pasqual G, Grabiner B
Immunity. 2017; 46(6):1045-1058.e6.
PMID: 28636954
PMC: 5526448.
DOI: 10.1016/j.immuni.2017.06.005.
NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.
Karki R, Malireddi R, Zhu Q, Kanneganti T
Cell Cycle. 2017; 16(13):1243-1251.
PMID: 28598238
PMC: 5531621.
DOI: 10.1080/15384101.2017.1317414.
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Wang S, Cen X, Liang X, Tang Y
Oncotarget. 2016; 8(6):10650-10661.
PMID: 27788497
PMC: 5354689.
DOI: 10.18632/oncotarget.12890.